Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by superDimension Ltd..
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
superDimension Ltd.
Information provided by:
superDimension Ltd.
ClinicalTrials.gov Identifier:
NCT00817167
First received: January 1, 2009
Last updated: February 18, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is aimed to evaluate and describe the added value of inReach planning software on performance characteristics of standard bronchoscopy.
| Condition | Intervention |
|---|---|
|
Lung Disease |
Device: inReach bronchoscopy planning software Device: Standard lung CT viewer |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Open Label, Randomized, Comparative, Single Center, Pilot Study to Assess the Added Value of inReach Technology Software on Performance Characteristics of Standard Bronchoscopy. |
Further study details as provided by superDimension Ltd.:
Primary Outcome Measures:
- Bronchoscopy Diagnostic Yield, compared between two study groups and calculated as percentage of true diagnoses from total number of bronchoscopy procedures. [ Time Frame: Until the definitive diagnosis is obtained ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Bronchoscopy Safety Profile, compared between two groups and calculated as percentage of bronchoscopy-related adverse events. [ Time Frame: At discharge from bronchoscopy unit ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 30 |
| Study Start Date: | January 2009 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: inReach (A)
Bronchoscopy procedure is planned using inReach planning software
|
Device: inReach bronchoscopy planning software
inReach planning software creates three-dimensional lung CT reconstruction, enabling rapid virtual endoscopic depiction of the airways that allows to plan bronchoscopy virtually.
|
|
Active Comparator: Control (B)
Bronchoscopy procedure is planned using standard CT viewer software
|
Device: Standard lung CT viewer
CT viewer, used for standard bronchoscopy
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Candidates for non-emergency bronchoscopy
- Must provide signed informed consent
- Male or female above 18 years old
- Lung lesions up to 3 cm in size (in largest diameter), non-visible by standard bronchoscope
Exclusion Criteria:
- CT done over a month before the bronchoscopy procedure
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00817167
Contacts
| Contact: Avi Mann, MD | + 972 3 6973591 | mann@tasmc.health.gov.il |
| Contact: Yehuda Schwarz, MD | + 972 3 6973591 | schwarz@tasmc.health.gov.il |
Locations
| Israel | |
| Pulmonology Department, Tel Aviv Sourasky Medical Center | Recruiting |
| Tel Aviv, Israel | |
| Contact: Avi Mann, MD + 972 3 6973591 mann@tasmc.health.gov.il | |
| Contact: Yehuda Schwarz, MD + 972 3 6973591 schwarz@tasmc.health.gov.il | |
| Principal Investigator: Avi Mann, MD | |
| Sub-Investigator: Yehuda Schwarz, MD | |
Sponsors and Collaborators
superDimension Ltd.
Investigators
| Principal Investigator: | Avi Mann, MD | Pulmonology Department, Tel Aviv Sourasky Medical Center |
More Information
Additional Information:
superDimension Inc. 
Publications:
| Responsible Party: | Noreen Thompson / VP Marketing, superDimension Inc. |
| ClinicalTrials.gov Identifier: | NCT00817167 History of Changes |
| Other Study ID Numbers: | DPR0006 |
| Study First Received: | January 1, 2009 |
| Last Updated: | February 18, 2009 |
| Health Authority: | Israel: Ethics Commission |
Keywords provided by superDimension Ltd.:
|
Known or suspected lung disease Candidates for non-emergency bronchoscopy |
Additional relevant MeSH terms:
|
Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013